Business Context and Reporting Period
This Form 6-K filing by Galmed Pharmaceuticals Ltd. is dated September 20, 2024. The report serves to announce the scheduling of a Special General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this filing.
Guidance, Outlook, and Corporate Actions
The Company announced it will hold a Special General Meeting of Shareholders on Monday, October 14, 2024, at 5:00 p.m. (Israel time). The meeting will be held at the offices of Meitar | Law Offices in Ramat Gan, Israel. The filing incorporates the Notice of the Special General Meeting, Proxy Statement, and Proxy Card as exhibits.
Key Facts for Investor Verification
- Verify the date and time of the Special General Meeting: October 14, 2024, at 5:00 p.m. Israel time.
- Confirm the location of the meeting at Meitar | Law Offices, Ramat Gan, Israel.
- Review the attached Exhibit 99.1 (Notice and Proxy Statement) and Exhibit 99.2 (Proxy Card) for specific agenda items and voting instructions.
- Note that this filing contains no financial performance data.